Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 142.7 as Sell-Off Deepens

1 hour ago
share
Share Via
For the fifth consecutive session, Sanjivani Paranteral Ltd closed lower, breaching its 52-week low at Rs 142.7 on 25 Mar 2026, marking a significant 44.26% decline over the past year despite the broader market's modest losses.
Sanjivani Paranteral Ltd Falls to 52-Week Low of Rs 142.7 as Sell-Off Deepens

Price Action and Market Context

The stock opened the day with a 2.53% gain, touching an intraday high of Rs 155.95, but succumbed to selling pressure to close near its low at Rs 142.7, down 3.98% on the day. This underperformance was stark against the Pharmaceuticals & Biotechnology sector, which gained 2.4%, and the Sensex, which surged 2.1% to 75,623.09. Notably, Sanjivani Paranteral Ltd trades below all key moving averages — 5-day through 200-day — signalling sustained downward momentum. What is driving such persistent weakness in Sanjivani Paranteral Ltd when the broader market is in rally mode?

Valuation Metrics and Financial Ratios

Despite the share price decline, the company exhibits some robust financial metrics. The return on equity (ROE) stands at a healthy 16.64%, reflecting efficient management of shareholder funds. The debt servicing capacity is strong, with a Debt to EBITDA ratio of just 0.86 times, indicating manageable leverage. Operating profit has grown at an impressive annual rate of 62.32%, underscoring solid operational performance. The return on capital employed (ROCE) is 17.6%, and the enterprise value to capital employed ratio is a modest 3.7, suggesting a fair valuation relative to the company’s asset base. However, the price-to-earnings multiple is difficult to interpret given the stock’s micro-cap status and recent price volatility. With the stock at its weakest in 52 weeks, should you be buying the dip on Sanjivani Paranteral Ltd or does the data suggest staying on the sidelines?

Built for the long haul! Consecutive quarters of strong growth landed this Small Cap from Chemicals on our Reliable Performers list. Sustainable gains are clearly ahead!

  • - Long-term growth stock
  • - Multi-quarter performance
  • - Sustainable gains ahead

Invest for the Long Haul →

Quarterly Financial Performance

The latest quarterly results present a nuanced picture. Net sales reached a record Rs 22.06 crores, while PBDIT hit Rs 3.84 crores, the highest recorded for the company. Operating profit margin to net sales also improved to 17.41%, signalling operational leverage. Profit after tax rose 14.1% year-on-year, a positive contrast to the share price trajectory. However, the PEG ratio of 2.7 suggests that earnings growth is not fully reflected in the valuation, possibly due to market scepticism or liquidity constraints. Does the sell-off in Sanjivani Paranteral Ltd represent an overreaction to temporary headwinds, or is the market pricing in something deeper?

Technical Indicators

Technical signals remain predominantly bearish. The MACD is bearish on the weekly chart and mildly bearish monthly, while Bollinger Bands confirm downward pressure on both timeframes. The KST indicator aligns with this negative momentum, showing bearishness weekly and mild bearishness monthly. The Dow Theory also signals mild bearishness across weekly and monthly periods. The stock’s position below all major moving averages reinforces the downtrend. Limited positive signals from RSI, which shows no clear indication, suggest that the stock has yet to reach an oversold bounce. Is this a recovery or a dead-cat bounce given the technical backdrop?

Shareholding and Market Capitalisation

Sanjivani Paranteral Ltd remains a micro-cap stock with a market cap grade reflecting its small size. The majority of shares are held by non-institutional investors, indicating limited institutional support despite the stock’s recent weakness. This ownership structure may contribute to the stock’s volatility and lack of sustained buying interest. The absence of significant institutional accumulation at these levels contrasts with the persistent selling pressure in the open market.

Why settle for Sanjivani Paranteral Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Summary and Outlook

The 44.26% decline over the past year contrasts sharply with the company’s improving financials, including record quarterly sales and profit growth. The valuation metrics suggest the stock is trading at a discount relative to peers, yet the market’s persistent selling and technical indicators point to continued pressure. The divergence between rising profits and falling share price highlights a complex investment case. Buy, sell, or hold at a 52-week low? The complete multi-factor analysis of Sanjivani Paranteral Ltd weighs all these signals.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News